Rare diseases
Investigational molecules
Locations
Study on the Effects and Safety of Cemiplimab and BNT116 in Adults with Advanced Non-Small Cell Lung Cancer
GermanyPhase II Study of Cemiplimab to Spare Surgery in Patients with Locally Advanced Cutaneous Squamous Cell Carcinoma
ItalyStudy of Cemiplimab, Platinum and Gemcitabine in Treatment‑Naïve Patients with Advanced Squamous Non‑Small Cell Lung Cancer
ItalyEvaluation of recurrence‑free survival with cemiplimab immunotherapy in medically inoperable stage I non‑small cell lung cancer patients
The NetherlandsREGN10597 Alone or with Cemiplimab in Adults with Advanced Solid Tumours, Melanoma, or Clear-Cell Renal-Cell Carcinoma
FranceA study of cemiplimab in patients with locally advanced cutaneous squamous cell carcinoma
SpainStudy of cemiplimab with or without chemotherapy for non-small cell lung cancer patients with high PD-L1 levels to reduce rapid disease progression
ItalyStudy of cemiplimab with chemoradiotherapy for patients with locally advanced cervical cancer
ItalyStudy of MIDRIX-LUNG immunotherapy combined with anti-PD-1 treatment in patients with metastatic non-small-cell lung cancer
BelgiumLong-term follow-up study of fianlimab and cemiplimab combination treatment in adult patients with melanoma
IrelandStudy on Cemiplimab and Mitotane for Patients with Advanced Adrenocortical Cancer
ItalyStudy on Pembrolizumab, Atezolizumab, and Nivolumab with Carbon Ion Radiotherapy for Patients with Advanced Melanoma, Urothelial Carcinoma, NSCLC, or Head & Neck Cancer
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
